ARTICLE | Company News
DNAPrint, Beth Israel Deaconess Medical Center deal
April 11, 2005 7:00 AM UTC
DNAP acquired an exclusive worldwide license from the center to PT-401, an erythropoietin (EPO) dimer to treat anemia. DNAP plans to couple PT-401 with a genetic test for predicting response and indiv...